Literature DB >> 17515782

Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.

F Reed Johnson1, Semra Ozdemir, Ranjani Manjunath, A Brett Hauber, Steven P Burch, Thomas R Thompson.   

Abstract

BACKGROUND: Medication nonadherence is high among patients with bipolar disorder, and may lead to poor clinical outcomes, decreased quality of life, and increased resource utilization.
OBJECTIVE: To investigate the factors associated with nonadherence and to assess the effect of patient-stated preferences on stated adherence to hypothetical medications. RESEARCH
DESIGN: A choice-format stated-preference Web survey was administered. In each choice question, patients were asked to choose among 2 or 3 different hypothetical medications. Each choice question was followed by a question asking patients about their likely adherence to the selected medication alternative.
SUBJECTS: Patients (N = 469) with self-reported bipolar disorder completed the survey which was programmed and administered to members of a chronic-illness Web panel. MEASURES: Factors associated with stated adherence to current treatment were identified. The effects of socioeconomic characteristics and medication attributes on stated adherence to hypothetical medications were assessed.
RESULTS: Patient socioeconomic characteristics affect patients' adherence. Being white and having more education has a significant positive effect on adherence. Self-reported current adherence is a strong factor in predicting adherence for better medications. Medication outcome attributes, especially severity of depressive episodes, strongly influence patients' stated adherence to treatment. Weight gain and cognitive effects of a medication most significantly affected patients' likely adherence to medications for bipolar disorder.
CONCLUSIONS: Patients are the final health care decision makers; their satisfaction with a medication is likely to affect whether or not they adhere to the medication prescribed by their physician. In the case of bipolar disorder, this study suggests patients are likely to be more adherent to medications that reduce the severity of depressive episodes and do not cause weight gain or cognitive side effects. By understanding the factors that improve adherence, health care providers can optimize prescribing patterns, which may ultimately lead to more effective management and improvement in the patient's condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515782     DOI: 10.1097/MLR.0b013e318040ad90

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  48 in total

Review 1.  Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group.

Authors:  Pasquale De Fazio; Paolo Girardi; Giuseppe Maina; Massimo Carlo Mauri; Mauro Mauri; Palmiero Monteleone; Giulia Ida Perini; Giulio Perugi; Alessandro Rossi
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

2.  Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey.

Authors:  John A Bates; Richard Whitehead; Susan C Bolge; Edward Kim
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Survey-design and analytical strategies for better healthcare stated-choice studies.

Authors:  F Reed Johnson; Carol Mansfield
Journal:  Patient       Date:  2008-12-01       Impact factor: 3.883

Review 4.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Authors:  Jennifer B Levin; Anna Krivenko; Molly Howland; Rebecca Schlachet; Martha Sajatovic
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

5.  Quantifying Social Reinforcement Among Family Members on Adherence to Medications for Chronic Conditions: a US-Based Retrospective Cohort Study.

Authors:  Julie C Lauffenburger; Nazleen F Khan; Gregory Brill; Niteesh K Choudhry
Journal:  J Gen Intern Med       Date:  2018-11-07       Impact factor: 5.128

6.  Patient-Important Outcomes in the Long-Term Treatment of Bipolar Disorder: A Mixed-Methods Approach Investigating Relative Preferences and a Proposed Taxonomy.

Authors:  Øystein Eiring; Magne Nylenna; Kari Nytrøen
Journal:  Patient       Date:  2016-04       Impact factor: 3.883

7.  Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder.

Authors:  Martha Sajatovic; Janis H Jenkins; Kristin A Cassidy; David J Muzina
Journal:  J Affect Disord       Date:  2008-11-08       Impact factor: 4.839

8.  Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy.

Authors:  F Reed Johnson; George Van Houtven; Semra Ozdemir; Steve Hass; Jeff White; Gordon Francis; David W Miller; J Theodore Phillips
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

9.  Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic.

Authors:  Martha Sajatovic; Rosalinda V Ignacio; Jane A West; Kristin A Cassidy; Roknedin Safavi; Amy M Kilbourne; Frederic C Blow
Journal:  Compr Psychiatry       Date:  2008-08-23       Impact factor: 3.735

10.  Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations.

Authors:  Monali Bhosle; Joshua S Benner; Mitch Dekoven; Jeff Shelton
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.